

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial calcium ion transport (GO:0006851) | 5.53007493 |
| 2 | fatty acid elongation (GO:0030497) | 4.58062459 |
| 3 | behavioral response to nicotine (GO:0035095) | 3.85329402 |
| 4 | DNA methylation involved in gamete generation (GO:0043046) | 3.74691963 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.65895251 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 3.59764765 |
| 7 | cysteine metabolic process (GO:0006534) | 3.59328386 |
| 8 | low-density lipoprotein particle clearance (GO:0034383) | 3.55786880 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.53623379 |
| 10 | * autophagic vacuole fusion (GO:0000046) | 3.53440727 |
| 11 | mitochondrial calcium ion homeostasis (GO:0051560) | 3.48432543 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47445033 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47445033 |
| 14 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.42512248 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42392111 |
| 16 | regulation of cholesterol storage (GO:0010885) | 3.41209705 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37947229 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.36444389 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.36444389 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.36444389 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.36444389 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.36444389 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.36444389 |
| 24 | intra-S DNA damage checkpoint (GO:0031573) | 3.33811884 |
| 25 | piRNA metabolic process (GO:0034587) | 3.31090534 |
| 26 | protein carboxylation (GO:0018214) | 3.30188981 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.30188981 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.29471790 |
| 29 | positive regulation of interferon-alpha production (GO:0032727) | 3.27458968 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.24785984 |
| 31 | urea cycle (GO:0000050) | 3.23145100 |
| 32 | urea metabolic process (GO:0019627) | 3.23145100 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.23012781 |
| 34 | L-phenylalanine catabolic process (GO:0006559) | 3.23012781 |
| 35 | ubiquinone biosynthetic process (GO:0006744) | 3.19630022 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 3.18765519 |
| 37 | kynurenine metabolic process (GO:0070189) | 3.16443415 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 3.14898877 |
| 39 | positive regulation of granulocyte differentiation (GO:0030854) | 3.13209696 |
| 40 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.11247122 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.10373387 |
| 42 | indole-containing compound catabolic process (GO:0042436) | 3.10373387 |
| 43 | indolalkylamine catabolic process (GO:0046218) | 3.10373387 |
| 44 | response to thyroid hormone (GO:0097066) | 3.08940706 |
| 45 | complement activation, alternative pathway (GO:0006957) | 3.07741026 |
| 46 | regulation of interferon-alpha production (GO:0032647) | 3.07681423 |
| 47 | regulation of memory T cell differentiation (GO:0043380) | 3.06100557 |
| 48 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.03282773 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.03019859 |
| 50 | L-phenylalanine metabolic process (GO:0006558) | 3.03019859 |
| 51 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 3.01659922 |
| 52 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.00934971 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 3.00204013 |
| 54 | sulfur amino acid catabolic process (GO:0000098) | 2.99531953 |
| 55 | macrophage activation involved in immune response (GO:0002281) | 2.98617338 |
| 56 | proteasome assembly (GO:0043248) | 2.97712225 |
| 57 | protein K6-linked ubiquitination (GO:0085020) | 2.96217917 |
| 58 | neutrophil activation (GO:0042119) | 2.95040163 |
| 59 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.91855198 |
| 60 | neutrophil activation involved in immune response (GO:0002283) | 2.91743381 |
| 61 | terpenoid biosynthetic process (GO:0016114) | 2.91712877 |
| 62 | tryptophan metabolic process (GO:0006568) | 2.90489314 |
| 63 | leukocyte degranulation (GO:0043299) | 2.89345281 |
| 64 | phospholipid homeostasis (GO:0055091) | 2.88395471 |
| 65 | regulation of triglyceride catabolic process (GO:0010896) | 2.87716894 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 2.84443325 |
| 67 | nitrogen cycle metabolic process (GO:0071941) | 2.83106610 |
| 68 | urate metabolic process (GO:0046415) | 2.82848937 |
| 69 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.82844265 |
| 70 | valine metabolic process (GO:0006573) | 2.82038500 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 2.80783141 |
| 72 | negative regulation of fibrinolysis (GO:0051918) | 2.79757543 |
| 73 | lysine catabolic process (GO:0006554) | 2.78919591 |
| 74 | lysine metabolic process (GO:0006553) | 2.78919591 |
| 75 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.78231051 |
| 76 | diterpenoid biosynthetic process (GO:0016102) | 2.78046040 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 2.77425267 |
| 78 | phospholipid efflux (GO:0033700) | 2.76601846 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 2.76517070 |
| 80 | growth hormone receptor signaling pathway (GO:0060396) | 2.75066882 |
| 81 | actin nucleation (GO:0045010) | 2.72250079 |
| 82 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.72206976 |
| 83 | NADH dehydrogenase complex assembly (GO:0010257) | 2.72206976 |
| 84 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.72206976 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.70146276 |
| 86 | regulation of transcription elongation from RNA polymerase II promoter (GO:0034243) | 2.69762127 |
| 87 | serine family amino acid catabolic process (GO:0009071) | 2.69549303 |
| 88 | regulation of protein activation cascade (GO:2000257) | 2.69010120 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 2.68885739 |
| 90 | glyoxylate metabolic process (GO:0046487) | 2.67892754 |
| 91 | positive regulation of lipid storage (GO:0010884) | 2.67784400 |
| 92 | hepatocyte apoptotic process (GO:0097284) | 2.67542262 |
| 93 | carnitine metabolic process (GO:0009437) | 2.67214873 |
| 94 | negative regulation of cholesterol transport (GO:0032375) | 2.66901620 |
| 95 | negative regulation of sterol transport (GO:0032372) | 2.66901620 |
| 96 | ubiquinone metabolic process (GO:0006743) | 2.65924018 |
| 97 | amino acid salvage (GO:0043102) | 2.64841056 |
| 98 | L-methionine salvage (GO:0071267) | 2.64841056 |
| 99 | L-methionine biosynthetic process (GO:0071265) | 2.64841056 |
| 100 | thrombin receptor signaling pathway (GO:0070493) | 2.64624196 |
| 101 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.64226514 |
| 102 | ATP synthesis coupled proton transport (GO:0015986) | 2.64226514 |
| 103 | reverse cholesterol transport (GO:0043691) | 2.63492910 |
| 104 | cellular defense response (GO:0006968) | 2.63226575 |
| 105 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.62833778 |
| 106 | homocysteine metabolic process (GO:0050667) | 2.61865151 |
| 107 | regulation of sequestering of triglyceride (GO:0010889) | 2.61566096 |
| 108 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.61417697 |
| 109 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.59834807 |
| 110 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.59620577 |
| 111 | bile acid biosynthetic process (GO:0006699) | 2.58798169 |
| 112 | regulation of mast cell activation (GO:0033003) | 2.58234702 |
| 113 | male meiosis I (GO:0007141) | 2.57929388 |
| 114 | myeloid cell activation involved in immune response (GO:0002275) | 2.57401217 |
| 115 | immunoglobulin mediated immune response (GO:0016064) | 2.57172898 |
| 116 | protein-lipid complex remodeling (GO:0034368) | 2.57089620 |
| 117 | macromolecular complex remodeling (GO:0034367) | 2.57089620 |
| 118 | plasma lipoprotein particle remodeling (GO:0034369) | 2.57089620 |
| 119 | regulation of complement activation (GO:0030449) | 2.56757955 |
| 120 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.56589598 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 2.56345758 |
| 122 | quinone biosynthetic process (GO:1901663) | 2.56027035 |
| 123 | cardiolipin metabolic process (GO:0032048) | 2.56000327 |
| 124 | regulation of mast cell degranulation (GO:0043304) | 2.53843756 |
| 125 | natural killer cell mediated immunity (GO:0002228) | 2.53308254 |
| 126 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.53308254 |
| 127 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.52820964 |
| 128 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.52820964 |
| 129 | tolerance induction (GO:0002507) | 2.52197929 |
| 130 | gonadal mesoderm development (GO:0007506) | 2.51749018 |
| 131 | regulation of superoxide anion generation (GO:0032928) | 2.51404759 |
| 132 | protein-lipid complex assembly (GO:0065005) | 2.51161008 |
| 133 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.51013466 |
| 134 | granulocyte activation (GO:0036230) | 2.50556732 |
| 135 | * organelle membrane fusion (GO:0090174) | 2.50509709 |
| 136 | electron transport chain (GO:0022900) | 2.50501723 |
| 137 | granulocyte differentiation (GO:0030851) | 2.49578328 |
| 138 | methionine biosynthetic process (GO:0009086) | 2.49234402 |
| 139 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.48926564 |
| 140 | respiratory burst (GO:0045730) | 2.48584415 |
| 141 | respiratory electron transport chain (GO:0022904) | 2.48105814 |
| 142 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.46753686 |
| 143 | regulation of gamma-delta T cell activation (GO:0046643) | 2.46697567 |
| 144 | DNA replication checkpoint (GO:0000076) | 2.46393220 |
| 145 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.45987089 |
| 146 | protein-cofactor linkage (GO:0018065) | 2.43812338 |
| 147 | B cell receptor signaling pathway (GO:0050853) | 2.43092830 |
| 148 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.42772606 |
| 149 | adenosine metabolic process (GO:0046085) | 2.42707697 |
| 150 | cholesterol efflux (GO:0033344) | 2.42223135 |
| 151 | negative regulation of lipid storage (GO:0010888) | 2.40980262 |
| 152 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.40854708 |
| 153 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.40699508 |
| 154 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.40537845 |
| 155 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.40160112 |
| 156 | positive regulation of interferon-beta production (GO:0032728) | 2.39529262 |
| 157 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.39378358 |
| 158 | negative regulation of lipid transport (GO:0032369) | 2.39362225 |
| 159 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.39001140 |
| 160 | drug transmembrane transport (GO:0006855) | 2.38673265 |
| 161 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.38536457 |
| 162 | regulation of B cell differentiation (GO:0045577) | 2.38532913 |
| 163 | DNA deamination (GO:0045006) | 2.37667058 |
| 164 | acute-phase response (GO:0006953) | 2.37532552 |
| 165 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.37401264 |
| 166 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.37401264 |
| 167 | positive regulation of hemostasis (GO:1900048) | 2.37301597 |
| 168 | positive regulation of blood coagulation (GO:0030194) | 2.37301597 |
| 169 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37200062 |
| 170 | plasma lipoprotein particle assembly (GO:0034377) | 2.36977444 |
| 171 | virion assembly (GO:0019068) | 2.36860398 |
| 172 | regulation of fibrinolysis (GO:0051917) | 2.36816554 |
| 173 | meiotic chromosome segregation (GO:0045132) | 2.36613308 |
| 174 | succinate metabolic process (GO:0006105) | 2.34497871 |
| 175 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.34444204 |
| 176 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.34180635 |
| 177 | positive regulation of defense response to virus by host (GO:0002230) | 2.34080615 |
| 178 | oxygen transport (GO:0015671) | 2.34039082 |
| 179 | cellular response to growth hormone stimulus (GO:0071378) | 2.33274632 |
| 180 | GMP metabolic process (GO:0046037) | 2.31844220 |
| 181 | gas transport (GO:0015669) | 2.30602849 |
| 182 | intracellular pH reduction (GO:0051452) | 2.30401144 |
| 183 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.28673115 |
| 184 | negative regulation of gene silencing (GO:0060969) | 2.28623620 |
| 185 | tRNA modification (GO:0006400) | 2.27933073 |
| 186 | protein deneddylation (GO:0000338) | 2.27759292 |
| 187 | nucleoside transmembrane transport (GO:1901642) | 2.27199568 |
| 188 | synapsis (GO:0007129) | 2.25309865 |
| 189 | viral protein processing (GO:0019082) | 2.24025643 |
| 190 | sleep (GO:0030431) | 2.21382181 |
| 191 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.20180531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.19990231 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.78430801 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.87441043 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.64770472 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.57909536 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.51590976 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.23210754 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.14809595 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.87344837 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.84041363 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.73754149 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.70405485 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.67260642 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63379147 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58815393 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57795578 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52428099 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.45249673 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.39874051 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38999861 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.36861523 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.33234872 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.30800800 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.28802024 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27330923 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18818791 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16804215 |
| 28 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14178452 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13563705 |
| 30 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13313994 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12814958 |
| 32 | * NCOR1_26117541_ChIP-Seq_K562_Human | 2.06516556 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.06461098 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.06335397 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.04592575 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98596241 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.95339712 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.94567854 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92873272 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.90167770 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.88148414 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86942355 |
| 43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.86185694 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86164121 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.84936991 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.82852169 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.82007101 |
| 48 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75543193 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.74418365 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.73224880 |
| 51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72335547 |
| 52 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.71923735 |
| 53 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.69454275 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.68096945 |
| 55 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.67690354 |
| 56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66788364 |
| 57 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66332036 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64906903 |
| 59 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.64573550 |
| 60 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63096199 |
| 61 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62803436 |
| 62 | MAF_26560356_Chip-Seq_TH1_Human | 1.61176632 |
| 63 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.58400072 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.55358449 |
| 65 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52709576 |
| 66 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.52404234 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.52126842 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50513406 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49634786 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49380922 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46192885 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46051323 |
| 73 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42935001 |
| 74 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41615165 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40473012 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.39723195 |
| 77 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39398535 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39224007 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38436977 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.37099266 |
| 81 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35732919 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35633761 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33606826 |
| 84 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33536418 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.33287833 |
| 86 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.33005479 |
| 87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.32060852 |
| 88 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.31340468 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31085004 |
| 90 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.30789837 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30312336 |
| 92 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.30170973 |
| 93 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30157078 |
| 94 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29795757 |
| 95 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.29062707 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28685489 |
| 97 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27820469 |
| 98 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27011391 |
| 99 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26267705 |
| 100 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25836611 |
| 101 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.25567822 |
| 102 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.24934350 |
| 103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23710950 |
| 104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22627360 |
| 105 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22218895 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21669992 |
| 107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19882399 |
| 108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17205294 |
| 109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16802880 |
| 110 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16546325 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16526561 |
| 112 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16010235 |
| 113 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15660923 |
| 114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15431030 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15079947 |
| 116 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.15020476 |
| 117 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14741325 |
| 118 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14540042 |
| 119 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14419455 |
| 120 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13305193 |
| 121 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.13291374 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12892970 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12528158 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 1.12507582 |
| 125 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11803799 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11706156 |
| 127 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11614385 |
| 128 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10943231 |
| 129 | ERA_21632823_ChIP-Seq_H3396_Human | 1.10904939 |
| 130 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.10866070 |
| 131 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10118747 |
| 132 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.09800475 |
| 133 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09561930 |
| 134 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.09141515 |
| 135 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08453385 |
| 136 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08382579 |
| 137 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08152649 |
| 138 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07227203 |
| 139 | MAF_26560356_Chip-Seq_TH2_Human | 1.06000476 |
| 140 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05491646 |
| 141 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05444302 |
| 142 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05035876 |
| 143 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04829048 |
| 144 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04499071 |
| 145 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04450958 |
| 146 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02607134 |
| 147 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02555720 |
| 148 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02480700 |
| 149 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02435462 |
| 150 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02367290 |
| 151 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02280327 |
| 152 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.02246863 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01487958 |
| 154 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01338130 |
| 155 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00516972 |
| 156 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00392062 |
| 157 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00034747 |
| 158 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97977660 |
| 159 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97147376 |
| 160 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92841527 |
| 161 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92417121 |
| 162 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92417121 |
| 163 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90497089 |
| 164 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88568384 |
| 165 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88140348 |
| 166 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87104956 |
| 167 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86026297 |
| 168 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85817576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.95149170 |
| 2 | MP0005360_urolithiasis | 3.84295261 |
| 3 | MP0004147_increased_porphyrin_level | 2.97292062 |
| 4 | MP0009840_abnormal_foam_cell | 2.80777407 |
| 5 | MP0003303_peritoneal_inflammation | 2.66762970 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.64596431 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.56293969 |
| 8 | MP0003436_decreased_susceptibility_to | 2.45597671 |
| 9 | MP0005365_abnormal_bile_salt | 2.42377326 |
| 10 | MP0004233_abnormal_muscle_weight | 2.42014925 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.39157609 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.38992108 |
| 13 | MP0003252_abnormal_bile_duct | 2.17074417 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.14501318 |
| 15 | MP0001727_abnormal_embryo_implantation | 2.06579550 |
| 16 | MP0001790_abnormal_immune_system | 1.97894379 |
| 17 | MP0005387_immune_system_phenotype | 1.97894379 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 1.97521813 |
| 19 | MP0010329_abnormal_lipoprotein_level | 1.94208436 |
| 20 | MP0000685_abnormal_immune_system | 1.92241975 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 1.90939130 |
| 22 | MP0001800_abnormal_humoral_immune | 1.90580640 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.89159255 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.87771688 |
| 25 | MP0003646_muscle_fatigue | 1.84423660 |
| 26 | MP0002419_abnormal_innate_immunity | 1.80676656 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.78443073 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.77604156 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.75671464 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.75534254 |
| 31 | MP0004947_skin_inflammation | 1.74017369 |
| 32 | MP0006082_CNS_inflammation | 1.71066469 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.67262181 |
| 34 | MP0000609_abnormal_liver_physiology | 1.66643714 |
| 35 | MP0005025_abnormal_response_to | 1.61224188 |
| 36 | MP0002653_abnormal_ependyma_morphology | 1.59106005 |
| 37 | MP0004043_abnormal_pH_regulation | 1.58203431 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.57391483 |
| 39 | MP0009785_altered_susceptibility_to | 1.55413468 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.52689982 |
| 41 | MP0002723_abnormal_immune_serum | 1.51702709 |
| 42 | MP0002876_abnormal_thyroid_physiology | 1.51360036 |
| 43 | MP0001661_extended_life_span | 1.50371735 |
| 44 | MP0005083_abnormal_biliary_tract | 1.48163617 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.42134868 |
| 46 | MP0002132_abnormal_respiratory_system | 1.41676388 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.40851527 |
| 48 | MP0009764_decreased_sensitivity_to | 1.40153502 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.38923213 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.38866184 |
| 51 | MP0001819_abnormal_immune_cell | 1.38643460 |
| 52 | MP0001853_heart_inflammation | 1.38110645 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.36684868 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.35805152 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.35145570 |
| 56 | MP0004130_abnormal_muscle_cell | 1.34539436 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.33691087 |
| 58 | MP0008995_early_reproductive_senescence | 1.33544279 |
| 59 | MP0005332_abnormal_amino_acid | 1.33520799 |
| 60 | MP0008260_abnormal_autophagy | 1.32942391 |
| 61 | MP0005451_abnormal_body_composition | 1.32450080 |
| 62 | MP0005671_abnormal_response_to | 1.30712903 |
| 63 | MP0008469_abnormal_protein_level | 1.30445925 |
| 64 | MP0006054_spinal_hemorrhage | 1.29562275 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.25333880 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.23363278 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.22803286 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 1.21131045 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 1.20728319 |
| 70 | MP0004145_abnormal_muscle_electrophysio | 1.20243561 |
| 71 | MP0008872_abnormal_physiological_respon | 1.20120019 |
| 72 | MP0004883_abnormal_blood_vessel | 1.19790680 |
| 73 | MP0003195_calcinosis | 1.19396749 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.18110538 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.17714187 |
| 76 | MP0002006_tumorigenesis | 1.15710173 |
| 77 | MP0009697_abnormal_copulation | 1.15446701 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.14707583 |
| 79 | MP0001764_abnormal_homeostasis | 1.14102864 |
| 80 | MP0004510_myositis | 1.13879988 |
| 81 | MP0000604_amyloidosis | 1.13512245 |
| 82 | MP0008775_abnormal_heart_ventricle | 1.13035823 |
| 83 | MP0003724_increased_susceptibility_to | 1.08735957 |
| 84 | MP0000716_abnormal_immune_system | 1.08013084 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07645002 |
| 86 | MP0003186_abnormal_redox_activity | 1.07100984 |
| 87 | MP0002398_abnormal_bone_marrow | 1.06407006 |
| 88 | MP0002405_respiratory_system_inflammati | 1.06210115 |
| 89 | MP0000689_abnormal_spleen_morphology | 1.04962657 |
| 90 | MP0000598_abnormal_liver_morphology | 1.02945192 |
| 91 | MP0003172_abnormal_lysosome_physiology | 1.01866396 |
| 92 | MP0009115_abnormal_fat_cell | 1.01515658 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 1.01465586 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 1.00924273 |
| 95 | MP0002136_abnormal_kidney_physiology | 1.00230606 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.98456785 |
| 97 | MP0008877_abnormal_DNA_methylation | 0.97855745 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.97618356 |
| 99 | MP0002796_impaired_skin_barrier | 0.97084167 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.96468157 |
| 101 | MP0000343_altered_response_to | 0.95749855 |
| 102 | MP0003448_altered_tumor_morphology | 0.95684848 |
| 103 | MP0000703_abnormal_thymus_morphology | 0.95353688 |
| 104 | MP0005166_decreased_susceptibility_to | 0.95132272 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.94270989 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.94054358 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.93607601 |
| 108 | MP0005164_abnormal_response_to | 0.93342113 |
| 109 | MP0001881_abnormal_mammary_gland | 0.92483091 |
| 110 | MP0009763_increased_sensitivity_to | 0.91325519 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.91047685 |
| 112 | MP0003959_abnormal_lean_body | 0.90847032 |
| 113 | MP0003866_abnormal_defecation | 0.90777986 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.89167643 |
| 115 | MP0002429_abnormal_blood_cell | 0.88890847 |
| 116 | MP0002254_reproductive_system_inflammat | 0.88870178 |
| 117 | MP0000858_altered_metastatic_potential | 0.88333169 |
| 118 | MP0005646_abnormal_pituitary_gland | 0.87796333 |
| 119 | MP0005023_abnormal_wound_healing | 0.87561341 |
| 120 | MP0003075_altered_response_to | 0.87426612 |
| 121 | MP0002722_abnormal_immune_system | 0.87372210 |
| 122 | MP0003786_premature_aging | 0.86116711 |
| 123 | MP0005535_abnormal_body_temperature | 0.85971338 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.84997439 |
| 125 | MP0000427_abnormal_hair_cycle | 0.84375542 |
| 126 | MP0003690_abnormal_glial_cell | 0.82835238 |
| 127 | MP0005670_abnormal_white_adipose | 0.82609489 |
| 128 | MP0005397_hematopoietic_system_phenotyp | 0.82479904 |
| 129 | MP0001545_abnormal_hematopoietic_system | 0.82479904 |
| 130 | MP0002971_abnormal_brown_adipose | 0.82086794 |
| 131 | MP0004142_abnormal_muscle_tone | 0.82079261 |
| 132 | MP0002970_abnormal_white_adipose | 0.81370300 |
| 133 | MP0005334_abnormal_fat_pad | 0.79285368 |
| 134 | MP0003011_delayed_dark_adaptation | 0.78058331 |
| 135 | MP0010307_abnormal_tumor_latency | 0.77978572 |
| 136 | MP0002933_joint_inflammation | 0.76814227 |
| 137 | MP0001915_intracranial_hemorrhage | 0.75661604 |
| 138 | MP0005376_homeostasis/metabolism_phenot | 0.74656446 |
| 139 | MP0003091_abnormal_cell_migration | 0.73333931 |
| 140 | MP0000249_abnormal_blood_vessel | 0.68830318 |
| 141 | MP0004264_abnormal_extraembryonic_tissu | 0.68662435 |
| 142 | MP0001873_stomach_inflammation | 0.68651024 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.67787130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperthyroidism (HP:0000836) | 4.82205015 |
| 2 | Petechiae (HP:0000967) | 4.81750809 |
| 3 | Truncus arteriosus (HP:0001660) | 4.51148266 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.10628445 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.02944387 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.00540666 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.83234626 |
| 8 | Prolonged bleeding time (HP:0003010) | 3.71524113 |
| 9 | Xanthomatosis (HP:0000991) | 3.70974103 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.63579426 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.63579426 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.63579426 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.55141459 |
| 14 | Myocardial infarction (HP:0001658) | 3.50495509 |
| 15 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.50492169 |
| 16 | Abnormality of alanine metabolism (HP:0010916) | 3.50492169 |
| 17 | Hyperalaninemia (HP:0003348) | 3.50492169 |
| 18 | Seborrheic dermatitis (HP:0001051) | 3.49110022 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.44249456 |
| 20 | Purpura (HP:0000979) | 3.42629833 |
| 21 | Hypertensive crisis (HP:0100735) | 3.31373542 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.31075671 |
| 23 | Complement deficiency (HP:0004431) | 3.29870897 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.19914053 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 3.07818386 |
| 26 | Tetraparesis (HP:0002273) | 2.97778146 |
| 27 | Obstructive lung disease (HP:0006536) | 2.96862429 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96862429 |
| 29 | Cellulitis (HP:0100658) | 2.91638457 |
| 30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.91628630 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 2.90404421 |
| 32 | Joint hemorrhage (HP:0005261) | 2.86305415 |
| 33 | Hypoparathyroidism (HP:0000829) | 2.82776485 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79961654 |
| 35 | Epistaxis (HP:0000421) | 2.78112967 |
| 36 | Tinnitus (HP:0000360) | 2.76080545 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.71786740 |
| 38 | Recurrent viral infections (HP:0004429) | 2.71496207 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.70884650 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.69781394 |
| 41 | Abnormality of complement system (HP:0005339) | 2.68256592 |
| 42 | Mitral stenosis (HP:0001718) | 2.67250028 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.66560436 |
| 44 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.63035616 |
| 45 | Epidermoid cyst (HP:0200040) | 2.61805443 |
| 46 | Increased serum ferritin (HP:0003281) | 2.61450907 |
| 47 | Poikilocytosis (HP:0004447) | 2.57722029 |
| 48 | Reticulocytosis (HP:0001923) | 2.56329498 |
| 49 | Recurrent skin infections (HP:0001581) | 2.54290497 |
| 50 | Papilloma (HP:0012740) | 2.53613386 |
| 51 | Verrucae (HP:0200043) | 2.53613386 |
| 52 | Agammaglobulinemia (HP:0004432) | 2.53603677 |
| 53 | Increased IgM level (HP:0003496) | 2.51597109 |
| 54 | Abnormal pupillary function (HP:0007686) | 2.51566682 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.50691707 |
| 56 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.49603951 |
| 57 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.49603951 |
| 58 | Pustule (HP:0200039) | 2.49492860 |
| 59 | Colitis (HP:0002583) | 2.46958707 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.43773276 |
| 61 | Menorrhagia (HP:0000132) | 2.41885369 |
| 62 | Hypobetalipoproteinemia (HP:0003563) | 2.39450085 |
| 63 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.38419633 |
| 64 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.38336334 |
| 65 | Abnormal large intestine physiology (HP:0012700) | 2.37876625 |
| 66 | Axonal loss (HP:0003447) | 2.37644401 |
| 67 | Atelectasis (HP:0100750) | 2.36922193 |
| 68 | Hematochezia (HP:0002573) | 2.36298818 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.36141581 |
| 70 | 3-Methylglutaconic aciduria (HP:0003535) | 2.35863210 |
| 71 | Polycythemia (HP:0001901) | 2.35287149 |
| 72 | Esophageal neoplasm (HP:0100751) | 2.34883696 |
| 73 | Neoplasm of head and neck (HP:0012288) | 2.34883696 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.34697720 |
| 75 | Glomerulonephritis (HP:0000099) | 2.34615135 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.34590339 |
| 77 | Gingival bleeding (HP:0000225) | 2.34490236 |
| 78 | Abnormality of dental color (HP:0011073) | 2.33547656 |
| 79 | Acne (HP:0001061) | 2.32658624 |
| 80 | Vacuolated lymphocytes (HP:0001922) | 2.32283302 |
| 81 | Prolonged partial thromboplastin time (HP:0003645) | 2.30726241 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.28977962 |
| 83 | Mucopolysacchariduria (HP:0008155) | 2.28526979 |
| 84 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28526979 |
| 85 | Hepatic necrosis (HP:0002605) | 2.28027296 |
| 86 | Esophageal varix (HP:0002040) | 2.27254997 |
| 87 | Granulocytopenia (HP:0001913) | 2.26891204 |
| 88 | Bowel incontinence (HP:0002607) | 2.26777659 |
| 89 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26464723 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 2.25107331 |
| 91 | Anorexia (HP:0002039) | 2.23425549 |
| 92 | Vasculitis (HP:0002633) | 2.18969370 |
| 93 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.18804712 |
| 94 | Disinhibition (HP:0000734) | 2.18251311 |
| 95 | Hepatocellular carcinoma (HP:0001402) | 2.17538650 |
| 96 | Birth length less than 3rd percentile (HP:0003561) | 2.17409128 |
| 97 | Acute necrotizing encephalopathy (HP:0006965) | 2.17087540 |
| 98 | Hemorrhage of the eye (HP:0011885) | 2.16395925 |
| 99 | Nephritis (HP:0000123) | 2.15828683 |
| 100 | Sparse lateral eyebrow (HP:0005338) | 2.14731487 |
| 101 | Increased IgE level (HP:0003212) | 2.14159881 |
| 102 | Dysostosis multiplex (HP:0000943) | 2.13734549 |
| 103 | Urticaria (HP:0001025) | 2.13533561 |
| 104 | Concave nail (HP:0001598) | 2.13489612 |
| 105 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.13285531 |
| 106 | Osteomyelitis (HP:0002754) | 2.12089958 |
| 107 | Paralysis (HP:0003470) | 2.11761092 |
| 108 | Periodontitis (HP:0000704) | 2.11688456 |
| 109 | Impaired platelet aggregation (HP:0003540) | 2.10750308 |
| 110 | Abnormal platelet function (HP:0011869) | 2.10750308 |
| 111 | Abnormal hemoglobin (HP:0011902) | 2.10596475 |
| 112 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.09574036 |
| 113 | Gastrointestinal stroma tumor (HP:0100723) | 2.08746271 |
| 114 | Large for gestational age (HP:0001520) | 2.08631190 |
| 115 | Hyperammonemia (HP:0001987) | 2.08497693 |
| 116 | Hypercholesterolemia (HP:0003124) | 2.07958948 |
| 117 | Lactic acidosis (HP:0003128) | 2.07170010 |
| 118 | Renal cortical cysts (HP:0000803) | 2.06975425 |
| 119 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06387437 |
| 120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06387437 |
| 121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06387437 |
| 122 | Nausea (HP:0002018) | 2.05586477 |
| 123 | Abnormality of the tricuspid valve (HP:0001702) | 2.04736216 |
| 124 | Fat malabsorption (HP:0002630) | 2.02516313 |
| 125 | Mitochondrial inheritance (HP:0001427) | 2.02164849 |
| 126 | Congenital stationary night blindness (HP:0007642) | 2.00345197 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 2.00337229 |
| 128 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00337229 |
| 129 | Increased muscle lipid content (HP:0009058) | 1.99554487 |
| 130 | Increased CSF lactate (HP:0002490) | 1.99241281 |
| 131 | Upper limb muscle weakness (HP:0003484) | 1.98671289 |
| 132 | Inflammation of the large intestine (HP:0002037) | 1.96925731 |
| 133 | Myositis (HP:0100614) | 1.96618261 |
| 134 | Hyperglycinuria (HP:0003108) | 1.96480857 |
| 135 | Gout (HP:0001997) | 1.95489038 |
| 136 | Cerebral palsy (HP:0100021) | 1.95386821 |
| 137 | Mediastinal lymphadenopathy (HP:0100721) | 1.94838347 |
| 138 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94821239 |
| 139 | Acute encephalopathy (HP:0006846) | 1.94704924 |
| 140 | Arterial thrombosis (HP:0004420) | 1.94553984 |
| 141 | Ketosis (HP:0001946) | 1.93049781 |
| 142 | Abnormality of the intrinsic pathway (HP:0010989) | 1.92825211 |
| 143 | Retrobulbar optic neuritis (HP:0100654) | 1.92309873 |
| 144 | Optic neuritis (HP:0100653) | 1.92309873 |
| 145 | Chronic otitis media (HP:0000389) | 1.91270220 |
| 146 | Gingivitis (HP:0000230) | 1.90801211 |
| 147 | Mucosal telangiectasiae (HP:0100579) | 1.90389157 |
| 148 | Orchitis (HP:0100796) | 1.89557129 |
| 149 | Increased serum lactate (HP:0002151) | 1.89429024 |
| 150 | Recurrent bronchitis (HP:0002837) | 1.88703688 |
| 151 | Hepatocellular necrosis (HP:0001404) | 1.88631351 |
| 152 | Stomatitis (HP:0010280) | 1.88087247 |
| 153 | Ileus (HP:0002595) | 1.88086007 |
| 154 | Beaking of vertebral bodies (HP:0004568) | 1.87487661 |
| 155 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87344417 |
| 156 | Hyperbilirubinemia (HP:0002904) | 1.87019175 |
| 157 | Gastrointestinal inflammation (HP:0004386) | 1.86480336 |
| 158 | Cholecystitis (HP:0001082) | 1.85495412 |
| 159 | Abnormal gallbladder physiology (HP:0012438) | 1.85495412 |
| 160 | Abnormality of reticulocytes (HP:0004312) | 1.84689341 |
| 161 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84269128 |
| 162 | Pulmonary embolism (HP:0002204) | 1.84007091 |
| 163 | Hypokinesia (HP:0002375) | 1.83393544 |
| 164 | Protuberant abdomen (HP:0001538) | 1.81870535 |
| 165 | Meningitis (HP:0001287) | 1.81652808 |
| 166 | Peritonitis (HP:0002586) | 1.80687841 |
| 167 | Hydroxyprolinuria (HP:0003080) | 1.80466853 |
| 168 | Abnormality of proline metabolism (HP:0010907) | 1.80466853 |
| 169 | Abnormal platelet volume (HP:0011876) | 1.80312222 |
| 170 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.79783661 |
| 171 | Opisthotonus (HP:0002179) | 1.79433584 |
| 172 | Abnormality of glycine metabolism (HP:0010895) | 1.79417980 |
| 173 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.79417980 |
| 174 | Increased CSF protein (HP:0002922) | 1.79246257 |
| 175 | Hypoglycemic coma (HP:0001325) | 1.78118900 |
| 176 | Conjunctival hamartoma (HP:0100780) | 1.75870857 |
| 177 | Encephalitis (HP:0002383) | 1.75653051 |
| 178 | Hypergammaglobulinemia (HP:0010702) | 1.75281236 |
| 179 | Autoimmune hemolytic anemia (HP:0001890) | 1.75244658 |
| 180 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75022303 |
| 181 | Gastrointestinal infarctions (HP:0005244) | 1.73997800 |
| 182 | Redundant skin (HP:0001582) | 1.73855220 |
| 183 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.73784737 |
| 184 | Ulnar bowing (HP:0003031) | 1.73552904 |
| 185 | Subacute progressive viral hepatitis (HP:0006572) | 1.73240553 |
| 186 | Increased mean platelet volume (HP:0011877) | 1.68830199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.16641208 |
| 2 | EIF2AK1 | 3.36777822 |
| 3 | ERN1 | 3.19849150 |
| 4 | TXK | 2.96798617 |
| 5 | WNK4 | 2.65576104 |
| 6 | MAP3K10 | 2.64753706 |
| 7 | MAP4K1 | 2.43681851 |
| 8 | STK10 | 2.41359595 |
| 9 | TYK2 | 2.40740908 |
| 10 | AKT3 | 2.25804623 |
| 11 | FGFR4 | 2.25453256 |
| 12 | PKN2 | 2.22112900 |
| 13 | NME1 | 2.19837201 |
| 14 | TESK2 | 2.17440273 |
| 15 | TLK1 | 2.15606829 |
| 16 | TBK1 | 2.15024093 |
| 17 | MAP3K14 | 2.14204625 |
| 18 | LRRK2 | 2.12017798 |
| 19 | MAPKAPK3 | 2.03288831 |
| 20 | BLK | 2.02930285 |
| 21 | JAK1 | 1.76490169 |
| 22 | PIK3CG | 1.76081665 |
| 23 | JAK3 | 1.65143872 |
| 24 | ILK | 1.65079337 |
| 25 | ADRBK2 | 1.64511893 |
| 26 | PTK6 | 1.58340785 |
| 27 | RIPK1 | 1.58052034 |
| 28 | TAOK3 | 1.54413477 |
| 29 | GRK6 | 1.52986551 |
| 30 | STK3 | 1.50543141 |
| 31 | MAP3K11 | 1.49989887 |
| 32 | FGFR3 | 1.48672221 |
| 33 | CDK6 | 1.45457655 |
| 34 | INSRR | 1.44653311 |
| 35 | IRAK1 | 1.44227634 |
| 36 | EPHB1 | 1.43457125 |
| 37 | KSR1 | 1.43442507 |
| 38 | IRAK3 | 1.41924648 |
| 39 | SIK1 | 1.39246738 |
| 40 | STK16 | 1.36828427 |
| 41 | BMPR2 | 1.35483194 |
| 42 | NEK9 | 1.32322063 |
| 43 | EEF2K | 1.27149351 |
| 44 | LATS1 | 1.26014671 |
| 45 | CSK | 1.25567693 |
| 46 | ZAP70 | 1.24194407 |
| 47 | RPS6KA4 | 1.22666410 |
| 48 | MST1R | 1.20624379 |
| 49 | CSF1R | 1.20268917 |
| 50 | RIPK4 | 1.19853998 |
| 51 | TGFBR2 | 1.18357032 |
| 52 | SCYL2 | 1.13585784 |
| 53 | MARK3 | 1.13508595 |
| 54 | SYK | 1.13228321 |
| 55 | PBK | 1.12904581 |
| 56 | MATK | 1.12825954 |
| 57 | NTRK3 | 1.11178123 |
| 58 | PIM1 | 1.09431898 |
| 59 | MAP2K6 | 1.09160243 |
| 60 | STK24 | 1.06890728 |
| 61 | JAK2 | 1.06495914 |
| 62 | CAMK1D | 1.05593762 |
| 63 | BTK | 1.03224187 |
| 64 | FRK | 1.01513994 |
| 65 | MAP4K2 | 0.98753694 |
| 66 | MAP2K3 | 0.96475543 |
| 67 | MAP2K2 | 0.96036519 |
| 68 | FGFR2 | 0.95926454 |
| 69 | IKBKB | 0.95660911 |
| 70 | CLK1 | 0.95233727 |
| 71 | HCK | 0.94773820 |
| 72 | BMX | 0.94682755 |
| 73 | IKBKE | 0.94349358 |
| 74 | TTN | 0.93010075 |
| 75 | CDK19 | 0.92786623 |
| 76 | CDK12 | 0.89927283 |
| 77 | PTK2B | 0.89637272 |
| 78 | ITK | 0.89473286 |
| 79 | PIM2 | 0.89426069 |
| 80 | MAP3K3 | 0.89225267 |
| 81 | MAP3K1 | 0.88442445 |
| 82 | RAF1 | 0.88061074 |
| 83 | MYLK | 0.87493909 |
| 84 | BCKDK | 0.87187843 |
| 85 | MAP3K5 | 0.84647199 |
| 86 | IRAK4 | 0.79654297 |
| 87 | KIT | 0.79550669 |
| 88 | STK4 | 0.77131535 |
| 89 | CHUK | 0.76258120 |
| 90 | ADRBK1 | 0.75658413 |
| 91 | RET | 0.74492589 |
| 92 | BRAF | 0.74403643 |
| 93 | MAPK12 | 0.73774753 |
| 94 | TRPM7 | 0.72715102 |
| 95 | KSR2 | 0.71954340 |
| 96 | MAP3K8 | 0.70889902 |
| 97 | DMPK | 0.69314748 |
| 98 | CDK4 | 0.69081057 |
| 99 | ABL2 | 0.68023833 |
| 100 | MST4 | 0.66592530 |
| 101 | MAP3K2 | 0.65605321 |
| 102 | PRKD2 | 0.65389419 |
| 103 | EPHA3 | 0.65057189 |
| 104 | PDGFRA | 0.64538979 |
| 105 | PRKCQ | 0.63952161 |
| 106 | EGFR | 0.63376013 |
| 107 | LYN | 0.62896137 |
| 108 | PIK3CA | 0.60923826 |
| 109 | ACVR1B | 0.60467359 |
| 110 | PDGFRB | 0.60236404 |
| 111 | ABL1 | 0.59673170 |
| 112 | HIPK2 | 0.59501245 |
| 113 | MAPK11 | 0.59452760 |
| 114 | FES | 0.59216150 |
| 115 | DYRK1B | 0.59066839 |
| 116 | ALK | 0.58641484 |
| 117 | PDK1 | 0.58355774 |
| 118 | CCNB1 | 0.57883124 |
| 119 | LCK | 0.57700746 |
| 120 | PTK2 | 0.56365394 |
| 121 | TEC | 0.53646766 |
| 122 | FLT3 | 0.51929135 |
| 123 | PDPK1 | 0.51694590 |
| 124 | PAK1 | 0.50608442 |
| 125 | MAP3K13 | 0.49999102 |
| 126 | TAOK1 | 0.49478911 |
| 127 | FGR | 0.49205956 |
| 128 | CAMKK2 | 0.48768484 |
| 129 | MAPKAPK2 | 0.48628833 |
| 130 | PRKD1 | 0.47294671 |
| 131 | PRKCI | 0.47256568 |
| 132 | MELK | 0.45592096 |
| 133 | PINK1 | 0.43965658 |
| 134 | MAP3K12 | 0.42862324 |
| 135 | TESK1 | 0.42589578 |
| 136 | CAMK1G | 0.42145668 |
| 137 | MAPK4 | 0.42086268 |
| 138 | MAP2K1 | 0.41231230 |
| 139 | CDK9 | 0.40471768 |
| 140 | ERBB4 | 0.40142927 |
| 141 | NUAK1 | 0.39812405 |
| 142 | MTOR | 0.39587563 |
| 143 | AURKA | 0.39576035 |
| 144 | GSK3A | 0.39415391 |
| 145 | PDK2 | 0.39102835 |
| 146 | MET | 0.38438004 |
| 147 | MAP3K6 | 0.32385150 |
| 148 | RPS6KB2 | 0.31862036 |
| 149 | GRK7 | 0.30263896 |
| 150 | GRK1 | 0.28594532 |
| 151 | SIK3 | 0.28581535 |
| 152 | FER | 0.25985940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.25237628 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.13722986 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.79948771 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.65668737 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.64482588 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.58307695 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.50735849 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.40082790 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.34757844 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.30334175 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.28527420 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.27021778 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.20748576 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.20690985 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.11717891 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.93677149 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.89443200 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87714520 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84717368 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.81304480 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.81274762 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80000984 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78952084 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.76911744 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.74629910 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.74451585 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.71897781 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.71454661 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64390324 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.59604221 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50054130 |
| 32 | RNA polymerase_Homo sapiens_hsa03020 | 1.49797726 |
| 33 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.47219865 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45149204 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.44689558 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42944084 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.39708503 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.38219568 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38130429 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.31491679 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.30525305 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28506567 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28428800 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 1.25968175 |
| 45 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23376667 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22775645 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.22722913 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17913313 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.16812122 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.16524017 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15056441 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13088021 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 1.12980058 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11534669 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09856172 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02663496 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01776909 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 1.01637032 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00042917 |
| 60 | Measles_Homo sapiens_hsa05162 | 0.99866316 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99572839 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97565495 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.96903284 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96642143 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96371483 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.95208808 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93607597 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.91923447 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91448541 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91176321 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91061180 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.90735352 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90330961 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89143581 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87154445 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.86638192 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.85975090 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.85489242 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84158384 |
| 80 | Mismatch repair_Homo sapiens_hsa03430 | 0.83001874 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.82940309 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82862473 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81614604 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80259266 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79779028 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79314069 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79268897 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78670333 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78632651 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78487238 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.78200241 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.77057469 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76167494 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75318337 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74904122 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72867349 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.71135858 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70486614 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70329496 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69758406 |
| 101 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69331596 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.68403244 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65644340 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64858155 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64289842 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.63497851 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63434544 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63042014 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62639845 |
| 110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62393317 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62355957 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61300189 |
| 113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60409620 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60027352 |
| 115 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59967241 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59838204 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.59331925 |
| 118 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58900179 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.58398766 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58326114 |
| 121 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57522306 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56351795 |
| 123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56338371 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56205553 |
| 125 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55808815 |
| 126 | Hepatitis B_Homo sapiens_hsa05161 | 0.54583257 |
| 127 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54394159 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54025631 |
| 129 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53215311 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53109672 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52631472 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.51913948 |
| 133 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50769840 |
| 134 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50492936 |
| 135 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50085767 |
| 136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49974135 |
| 137 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49962676 |
| 138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49384889 |
| 139 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48595747 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.47283518 |
| 141 | Base excision repair_Homo sapiens_hsa03410 | 0.46308453 |
| 142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45779923 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45288699 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45269485 |
| 145 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45014455 |
| 146 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45010224 |
| 147 | DNA replication_Homo sapiens_hsa03030 | 0.44936879 |
| 148 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44721830 |
| 149 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40593928 |
| 150 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40379040 |
| 151 | Endocytosis_Homo sapiens_hsa04144 | 0.39080964 |

